US Patent

US10342813 — Calcium gluconate solutions in flexible containers

Formulation · Assigned to HQ Specialty Pharma Corp · Expires 2037-07-25 · 11y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a terminally sterilized aqueous calcium gluconate solution packaged in a flexible plastic container with specific weight percentages of calcium gluconate and calcium saccharate.

USPTO Abstract

A terminally sterilized aqueous calcium gluconate solution comprising 1 to 15 wt. % calcium gluconate and from 1 to 19 wt. parts of calcium saccharate per 100 wt. parts of calcium gluconate packaged in a flexible plastic container with the remainder water.

Drugs covered by this patent

Calcium Gluconate (CALCIUM GLUCONATE)

Patent Metadata

Patent number: US10342813
Jurisdiction: US
Classification: Formulation
Expires: 2037-07-25
Drug substance claim: No
Drug product claim: Yes
Assignee: HQ Specialty Pharma Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.